In a vaccination assay, C56BL/6 mice pretreated with CVA21-lysed MB49-ICAM-1 bladder cancer cells were effectively protected from later challenge with the same cells injected into the opposite flank, compared to 50% of control mice challenged with uninfected lysate [37]. Here, ICAM1 is linked to urinary bladder carcinoma.